Stryker Hip Lawsuit News: Defendant Opposes Motion to Compel Document Production in Federal Stryker Hip Litigation, Bernstein Liebhard LLP Reports

The Firm is representing numerous Stryker hip recall clients who were allegedly injured by Stryker’s Rejuvenate and ABG II Modular-Neck Hip Stems.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Free Case Review
Our Firm is representing numerous Stryker hip lawsuit clients who have filed similar claims in New Jersey Superior Court that also name Howmedica Osteonics among the defendants. We are monitoring developments in the federal proceeding closely.

New York, NY (PRWEB) April 13, 2014

Stryker hip lawsuits (http://www.strykerhiprecallclaims.com/) filed in the wake of the 2012 Rejuvenate and ABG II Modular-Neck Hip Stem recall continue to move forward in state and federal courts around the U.S., Bernstein Liebhard LLP reports. According to a brief filed in the U.S. District Court, District of Minnesota on April 4, 2014, Howmedica Osteonics Corp., a defendant in Stryker hip recall claims, is opposing a motion to compel the production of certain documents and answers to interrogatories sought by plaintiffs with cases pending in the District. The brief asserts that plaintiffs have not explained why the information they are seeking is important to their claims. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244)

“Our Firm is representing numerous Stryker hip lawsuit clients who have filed similar claims in New Jersey Superior Court that also name Howmedica Osteonics among the defendants. We are monitoring developments in the federal proceeding closely,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who have suffered serious complications, allegedly related to the Stryker hip recall for Rejuvenate and ABG II hip stems.

Stryker Hip Recall Litigation
In 2012, Stryker recalled Rejuvenate and ABG II hip stems after post-market data indicated that an unacceptable number of recipients were experiencing pain, adverse local tissue reactions, and device failure due to fretting and corrosion at the modular-neck junction. At the time of the recall, some 20,000 of the affected hip stems were sold globally, but it is not known how many were implanted in patients. Stryker has recommended all patients who received a Rejuvenate or ABG II hip stem undergo blood and imaging tests to ensure their device is functioning properly, even if they have not experienced any symptoms related to a failing hip implant.*

According to court documents, more than 950 Stryker hip lawsuits stemming from the 2012 recall have been filed in a multicounty litigation underway in New Jersey’s Bergen County Superior Court, where Bernstein Liebhard LLP is currently filing claims. All of the complaints allege that the Rejuvenate and ABG II hip stems were defectively designed and manufactured, and caused recipients to suffer osteolysis, tissue necrosis, adverse local tissue reactions, and other debilitating complications. The lawsuits further allege that many affected by the Stryker hip recall continue to suffer from pain and disability, even after undergoing surgery to remove and replace their failing devices. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)

In addition to the claims pending in New Jersey, court documents indicate that more than 600 Stryker hip lawsuits involving Rejuvenate and ABG II hip stems have been consolidated in the federal multidistrict litigation now underway in U.S. District Court, District of Minnesota.

Individuals who were allegedly harmed by Rejuvenate and ABG II hip stems may be entitled to file their own Stryker hip lawsuit. To learn more about the Stryker hip recall, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.

*literature.ortho.stryker.com/files/REJUV_COM_23.pdf

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.strykerhiprecallclaims.com/
https://plus.google.com/115936073311125306742?rel=author